The Food and Drug Administration has approved Moderna's new COVID-19 vaccine, days after the federal government tightened ...

By The Associated Press The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use ...

The FDA has updated COVID-19 vaccine regulations. Only people aged 65 and up, along with certain groups, will be eligible to receive booster shots. FDA officials are asking for more data around ...

That's the same limit the FDA set in licensing another COVID-19 vaccine option from competitor Novavax. Those restrictions are a departure from how the U.S. has handled COVID-19 vaccines until now ...

Moderna announced this weekend that the Food and Drug Administration approved its lower-dose Covid-19 vaccine for adults 65 ...

That’s the same limit that the FDA set in licensing another COVID-19 vaccine option from competitor Novavax. Those restrictions are a departure from how the U.S. has handled COVID-19 vaccines ...

The FDA imposed similar limitations on Novavax’s Covid vaccine when it approved ... Trump administration’s call for tighter restrictions on vaccine eligibility and approvals.

The new low-dose vaccine is one-fifth the size ... aligning with the agency’s new restrictions for COVID-19 shots. “The FDA approval of our third product, mNexspike, adds an important new ...

Despite uncertainties arising from new FDA policies around COVID-19 vaccines, Moderna has cleared the agency's desk with its ...

That’s the same limit that the FDA set in licensing another COVID-19 vaccine option from competitor Novavax. Those restrictions are a departure from how the U.S. has handled COVID-19 vaccines ...